Previous studies have found that inhibiting the PI3K/AKT signaling pathway can effectively inhibit the function of pancreatic cancer; thus, we speculated that linderalactone functions in this way [16, 17]. The gene discussed is AKT1; the disease is pancreatic neoplasm.